Bill Lawrence, J.D., M.S., Ph.D.

Dr. Lawrence, an American Biogerontologist, brings a unique blend of qualifications to his research. His Jurisprudence Degree (UCLA-Law) provides a unique legal research perspective to his work, his MS in Psychology offers insights into human behavior and cognition, and his Ph.D. in Nutritional Science equips him with a deep understanding of the biological processes of aging. This multidisciplinary approach allows him to view aging from various angles, enhancing his ability to develop comprehensive solutions. Over three decades, he has applied this approach to focus on human longevity research and interventions for optimal life and health span. Dr. Lawrence is affiliated with the St. Petersburg Institute of Bioregulation and Gerontology (Russia), a hub of pioneering research in biogerontology. He is the administrator of two groundbreaking Russian and American longevity clinical studies: Telomerase Activation and DNA/Methylation Epigenetic Age Modification, which are at the forefront of longevity research. These studies and the significant results promise to revolutionize our understanding of the aging process and longevity interventions. At age 79, Dr. Lawrence’s research has profoundly slowed his aging process, enhancing his potential longevity and health span, as well as that of 150 clinical study participants, primarily physicians. His average telomere length, or “Cellular Age,” is equivalent to that of a 23-year-old. His “Epigenetic Age,” measured by the Horvath Epigenetic Clock (DNA/Methylation), is ten years less than his chronological age, resulting in a fifty percent reduction of all-cause mortality risk compared to his same-age peers. His annual biological rate of aging at 79% is twenty-one percent slower than his chronological yearly aging, a personal testament to the power of his research.